FDA fast tracks AstraZeneca diabetes drug
Farxiga is being given a speedy review prevent heart and kidney failure prevention for those with chronic kidney disease
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Cardiology | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Pharmaceuticals | Urology & Nephrology